November 11, 2024

More than financial support, a real opportunity for Élie Fiogbé

News

This year, the Centre de recherche du CHUS's postdoctoral fellowship, supported by Desjardins, was awarded to Élie Fiogbé, who will be able to continue his work on myotonic dystrophy type 1. This neuromuscular disease affects one in 8,000 people worldwide, but about one in 475 in Saguenay-Lac-St-Jean.

Marc Tremblay, patient, ainsi qu'Élie Fiogbé, récipiendaire de la bourse Desjardins
dystrophie myotonique de type 1 (DM1)
Bourse Desjardins
Fondation du CHUS
Centre de recherche du CHUS
Marc Tremblay, patient, and Élie Fiogbé, Desjardins bursary recipient

This two-year, $45,000 grant will enable her to carry out the project Integration of a respiratory muscle training program facilitated by telerehabilitation: a proof-of-concept study in a population suffering from myotonic dystrophy type 1 (DM1). Thank you to Desjardins for supporting the next generation of researchers!

"Thanks to the postdoctoral fellowship from the Centre de recherche du CHUS, I am making significant progress in my research on myotonic dystrophy type 1 (DM1), a rare neuromuscular disease that poses substantial clinical challenges. This fellowship is essential to the success of my project, which aims to develop innovative and accessible therapeutic interventions to enhance the quality of life for individuals with DM1.

From a scientific perspective, the fellowship allows me to fully leverage my expertise in cardiopulmonary rehabilitation and respiratory function assessment—fields critical for managing DM1, where respiratory complications are the leading cause of mortality. With the support provided by this fellowship, I can advance my research on heart rate variability and complexity, respiratory muscle strength, and the application of spirometry for patient monitoring. These competencies will help me design targeted respiratory rehabilitation programs to address the specific needs of DM1 patients and prevent the decline of their respiratory function.

Beyond the clinical aspect, the fellowship also provides me with the resources to explore innovative solutions to the challenges of accessibility to care faced by DM1 patients. Many patients experience limited access to rehabilitation programs due to factors such as distance, cost, or difficulties traveling to health centers. My project aims to address these barriers by developing (tele)rehabilitation programs that allow patients to receive treatment at home. This telehealth component is even more crucial in the current post-pandemic context, where remote care options have become essential.

Additionally, this fellowship offers me the opportunity to collaborate with world-renowned researchers, including DM1 specialist Prof. Cynthia Gagnon and strength-training program expert Prof. Élise Duchesne. Their expertise complements my own and fosters a unique synergy within our research team. Together, we can not only improve clinical outcomes for patients but also develop scalable and accessible solutions.

In summary, this fellowship is more than just financial support; it is a true opportunity for me to conduct high-impact research, propose practical solutions to the challenges of DM1, and make a meaningful difference in patients' lives. With this support, I am optimistic about making a lasting contribution to advancing knowledge and improving care for people with this disease."

- Élie Fiogbé

Thank you for giving for health!

Your involvement makes all the difference in achieving and pursuing the mission of the CHUS Foundation.

Annie Corriveau, directrice des communications à la Fondation du CHUS
For further information
Contact
Annie Corriveau
Director of Communications
by
email
or at
819 820-6450
Ext. 22906
Learn more about ways to give
Becoming a partner

News

September 5, 2024
Gentle care for children in the emergency room

Did you know that 14,000 children are received at the Fleurimont Hospital emergency room each year? These little cubs do not always like to undergo the good care of the staff who do their best to make a blood test pleasant!

News

September 5, 2024
50 years of care – 50 years of stories | Dany

Little Dany is 6 years old. He has just entered the first year of school and it is almost incredible, but for two years now, he has not had to worry about his food allergy to peanuts to the delight of his parents!

News

August 6, 2024
50 years of care – 50 years of stories | Laurence

Laurence has neurofibromatosis, a genetic disorder that causes tumors to form on nerve tissue. This incurable disease currently affects one in 3,000 people.

Sign up to our Newsletter

A dose of positivity, solidarity and hope, which reminds us that taking care of your health and that of others starts with a simple gesture.